Evaluations for Determination of Optimum Shields in Nuclear Medicine
Background: <sup>131</sup>I source is widely used in the treatment of hyperthyroidism and thyroid cancers. <sup><span>131</span></sup>I emits both beta and gamma-rays. Radiation protection is considered for gamma rays emitted by <sup><span>131</span...
Main Authors: | R parvaresh, M Jalili, A Haghparast, K Khoshgard, M T Eivazi, M Ghorbani |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2020-10-01
|
Series: | Journal of Biomedical Physics and Engineering |
Subjects: | |
Online Access: | https://jbpe.sums.ac.ir/article_46460_7cdd401e41c4924c9a7d07b2edb8b5df.pdf |
Similar Items
-
Implementation of internal monitoring programs for workers occupationally exposed by 131I in nuclear medicine services in Brazil
by: Salomão Marques de Oliveira, et al.
Published: (2018-07-01) -
Voxelized Dose Assessment for Radionuclide Therapy in Nuclear Medicine
by: MA Ruiyao;QIU Rui;WU Zhen;HU Ziyi;DAI Tiantian;GUO Feng;ZHAO Wenrui;JIANG Nianming;GAO Lilei;LI Junli
Published: (2023-06-01) -
Thyroid cell irradiation by radioiodines: a new Monte Carlo electron track-structure code
by: Christophe Champion, et al.
Published: (2007-09-01) -
Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated 131I dose
by: Ka Kit Wong, et al.
Published: (2018-11-01) -
Design shielding assessment for a nuclear medicine service
by: O Brígido Flores, et al.
Published: (2019-08-01)